Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01680484
Other study ID # HEK 10/117-13
Secondary ID
Status Completed
Phase N/A
First received September 4, 2012
Last updated September 6, 2012
Start date February 2011
Est. completion date January 2012

Study information

Verified date September 2012
Source Dr. Sami Ulus Children's Hospital
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Interventional

Clinical Trial Summary

There are multiple factors affecting the variability and acceleration pattern of fetal heart rate (FHR) pattern. However, fetal activity is considered as the main determinant. Any factor decreasing fetal activity causes a decrease in FHR variability. Fetal activity may be stimulated by manual manipulation, sound, light, change in maternal position and maternal ingestion of glucose. Among those, ingestion of any kind of food or juice is most frequently practiced in outpatient settings. This is not only medical but also a social routine. In this study the investigators have chosen the two most popular so-called 'fetal accelerators', chocolate and orange juice against no intervention and tried to find any usefulness of these on non-reactive NST patterns.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date January 2012
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- singleton pregnancies at 36 to 41 completed gestational weeks that have a non-reactive NST pattern without decelerations.

Exclusion Criteria:

- multiple pregnancies, fetal anomaly, hypertension, intrauterine growth restriction, active labor, contractions or decelerations on NST, absence of a first or second trimester ultrasonography for accurate gestational dating, pre-gestational or gestational diabetes and known allergy to chocolate or orange

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Bitter chocolate

Orange juice


Locations

Country Name City State
Turkey Dr. Sami Ulus Maternity and Children's Training and Research Hospital Ankara

Sponsors (1)

Lead Sponsor Collaborator
Dr. Sami Ulus Children's Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Increase in reactivity of NST 30 minutes No
Secondary Increase in the maternal fetal movement perception 30 minutes No
See also
  Status Clinical Trial Phase
Completed NCT05326269 - Acute Tocolysis With Terbutaline for Suspected Fetal Distress N/A